InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (4 ops.)
Insider track record
Board DirectorDisclosed buys
1
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by Patusky Christopher, Director. Director active across 1 company, notably UNITED THERAPEUTICS Corp. Cumulatively, 32 filings have been published. Breakdown: 1 buy · 4 sells. Total volume traded: €2.7m. History available since 6 May 2021. The latest transaction was disclosed on 9 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Patusky Christopher
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
650 shares0Common StockSEC:0001231427-26-000003:0
2,910 shares@ US$101.800.0012% mcap3.6% of flowCommon StockSEC:0001231427-26-000002:0
2,910 shares@ US$569.000.0068% mcap20.4% of flowCommon StockSEC:0001231427-26-000002:1
1,000 shares@ US$101.800.0004% mcap1.1% of flowCommon StockSEC:0001231427-26-000001:0
1,000 shares@ US$578.880.0024% mcap6.5% of flowCommon StockSEC:0001231427-26-000001:1
1,000 shares@ US$101.801.3% of flowCommon StockSEC:0001231427-25-000004:0
590 shares0Common StockSEC:0001562180-25-005530:0
5,000 shares@ US$175.4315.2% of flowCommon StockSEC:0001562180-25-002636:0
5,000 shares@ US$175.4316.1% of flowCommon StockSEC:0001562180-25-000328:0
700 shares@ US$175.432.1% of flowCommon StockSEC:0001415889-24-022908:0
900 shares0Common StockSEC:0001415889-24-019551:0
2,000 shares@ US$76.362.7% of flowCommon StockSEC:0001415889-24-017414:0
1,310 shares@ US$76.261.7% of flowCommon StockSEC:0001415889-24-013238:0
1,680 shares@ US$224.006.6% of flowCommon StockSEC:0001415889-24-005245:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-014891:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-012408:0
2,000 shares@ US$88.033.0% of flowCommon StockSEC:0001415889-23-007817:0
3 shares@ US$130.240.0% of flowCommon StockSEC:0001104659-23-055524:0
Canonical exit: 15 Oct 2017 (T+90)
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-005017:0
2,000 shares@ US$88.033.1% of flowCommon StockSEC:0001415889-23-000308:0
1,500 shares@ US$88.032.4% of flowCommon StockSEC:0001415889-22-011591:0
1,500 shares@ US$63.901.8% of flowCommon StockSEC:0001415889-22-008821:0
2,000 shares@ US$63.900.0005% mcap6.4% of flowCommon StockSEC:0001415889-22-005241:0
2,000 shares@ US$63.900.0005% mcap6.2% of flowCommon StockSEC:0001415889-22-003960:0
2,000 shares@ US$88.030.0007% mcap8.5% of flowCommon StockSEC:0001415889-22-003051:0
25 of 32 declarations
About Patusky Christopher
PATUSKY CHRISTOPHER is Administrateur and a Director at UNITED THERAPEUTICS Corp, XNAS. He has 32 filings in total, and across the sampled recent filings from 2016-01-08 to 2026-07-13, purchases total 341 EUR and sales total 2654009 EUR, with the most frequent transaction nature shown as Levée d'options.
